Skip to main content
. 2017 Dec 23;9(2):2678–2696. doi: 10.18632/oncotarget.23626

Figure 1. A flowchart depicting the outline of the study.

Figure 1

Workflow and steps evolved for the metabolomic study conducted on tissue (24 IDC, 24 benign and 24 normal) and serum (76 IDC, 33 benign and 33 control) samples using targeted liquid chromatography multiple reaction monitoring mass spectrometry (LC-MRM/MS) and untargeted gas chromatography mass spectrometry (GC-MS) approaches are shown. [Legends: HILIC-Hydrophilic interaction chromatography (HILIC column), RPLC T3: Reverse phase chromatography (T3 column)].